HCP
62
2
MA
67
2
LB
49
-14
OI
38
-4
CHRW
42
-12
CMS
61
-3
HUM
48
7
EBAY
44
-3
PNC
65
-2
EW
41
-5
SLB
56
3
ZTS
49
-5
FMC
34
-2
FIS
46
-2
AVGO
22
4
TROW
59
-3
RIG
61
6
HSY
40
3
EIX
77
-3
CA
54
4
HCP
62
2
MA
67
2
LB
49
-14
OI
38
-4
CHRW
42
-12
CMS
61
-3
HUM
48
7
EBAY
44
-3
PNC
65
-2
EW
41
-5
SLB
56
3
ZTS
49
-5
FMC
34
-2
FIS
46
-2
AVGO
22
4
TROW
59
-3
RIG
61
6
HSY
40
3
EIX
77
-3
CA
54
4
Financhill
Back

Greenlane Holdings Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
34

GNLN
Greenlane Holdings

Last Price:
1.81
Seasonality Move:
-9.22%
Buy
58

SRPT
Sarepta Therapeutics

Last Price:
133.49
Seasonality Move:
14.88%
Sell
34
Greenlane Holdings (GNLN) is a Sell

Is Greenlane Holdings a Buy, Sell or Hold?

  • The current Greenlane Holdings [GNLN] share price is $1.83. The Score for GNLN is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • GNLN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
58
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $133.34. The Score for SRPT is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

GNLN Stock Price Chart

What is Greenlane Holdings's stock price today?

  • The Greenlane Holdings share price today is $1.83
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GNLN is experiencing selling pressure, which indicates risk of future bearish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $133.34
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

GNLN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.47 Sell
Relative Strength Index (14 RSI): 33.84 Sell
Chaikin Money Flow: -30618 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.73 - 2.87) Sell
Bollinger Bands (100): (1.85 - 6.75) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.78 Buy
Relative Strength Index (14 RSI): 63.54 Buy
Chaikin Money Flow: -725343 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (110.85 - 129.81) Buy
Bollinger Bands (100): (119.21 - 141.67) Buy

GNLN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.82 Buy
20-day SMA: 2.11 Sell
50-day SMA: 3.41 Sell
200-day SMA: 4.93 Sell
8-day EMA: 1.87 Sell
20-day EMA: 2.21 Sell
50-day EMA: 3.14 Sell
200-day EMA: 11.64 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 119.83 Buy
20-day SMA: 118.14 Buy
50-day SMA: 122.33 Buy
200-day SMA: 130.09 Buy
8-day EMA: 123.82 Buy
20-day EMA: 120.48 Buy
50-day EMA: 122.96 Buy
200-day EMA: 126.17 Buy

Greenlane Holdings Earnings Growth & GNLN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.75 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $7.74 per share.

Greenlane Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):